Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
January 30, 2020
January 30, 2020
NEW BRUNSWICK, New Jersey, Jan. 30 -- Johnson & Johnson issued the following news release on Jan. 29:
* * *
- Initiating Vaccine Development and Providing Supplies of Antiviral Medicines to China for Investigational Use
* * *
Johnson & Johnson announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as 2019-nCoV or Wuhan coronavirus) outbrea . . .
* * *
- Initiating Vaccine Development and Providing Supplies of Antiviral Medicines to China for Investigational Use
* * *
Johnson & Johnson announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as 2019-nCoV or Wuhan coronavirus) outbrea . . .